Title: Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for
Helicobacter pylori infection in China: A three-arm, randomised clinical trial protocol
Version: 1 Date: 25 Apr 2023
Reviewer's report:
This study was tried to evaluation of Vonoprazan-based triple and dual therapy not inferior to
bismuth-based quadruple therapy for Helicobacter pylori infection in China.
Detail description of study designed, and method were found.
However, no clear study result and short discussion in this manuscription.
Besides, I did not see any table 1.
Did this manuscription completed finish?
Title: Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for
Helicobacter pylori infection in China: A three-arm, randomised clinical trial protocol
Version: 1 Date: 25 Apr 2023
Reviewer's report:
This study was tried to evaluation of Vonoprazan-based triple and dual therapy not inferior to
bismuth-based quadruple therapy for Helicobacter pylori infection in China.
Detail description of study designed, and method were found.
However, no clear study result and short discussion in this manuscription.
Besides, I did not see any table 1.
Did this manuscription completed finish?
Please review this paper.
user
Title: Vonoprazan-based triple and dual therapy versus bismuth-based quadruple therapy for
Helicobacter pylori infection in China: A three-arm, randomised clinical trial protocol
Version: 1 Date: 25 Apr 2023
Reviewer's report:
This study was tried to evaluation of Vonoprazan-based triple and dual therapy not inferior to
bismuth-based quadruple therapy for Helicobacter pylori infection in China.
Detail description of study designed, and method were found.
However, no clear study result and short discussion in this manuscription.
Besides, I did not see any table 1.
Did this manuscription completed finish?
assistant